Oral Administration of Saccharomyces boulardii Ameliorates Carbon Tetrachloride-Induced Liver Fibrosis in Rats via Reducing Intestinal Permeability and Modulating Gut Microbial Composition

Interactions Between the Intestinal Microbiome and Liver Diseases

(2014) Bernd Schnabl et al.   GASTROENTEROLOGY

CCL20 mediates lipopolysaccharide induced liver injury and is a potential driver of inflammation and fibrosis in alcoholic hepatitis

(2014) Silvia Affò et al.   GUT

Oral probiotic VSL#3 attenuates the circulatory disturbances of patients with cirrhosis and ascites

(2014) Diego Rincón et al.   LIVER INTERNATIONAL

VSL#3 probiotic treatment decreases bacterial translocation in rats with carbon tetrachloride-induced cirrhosis

(2014) Elisabet Sánchez et al.   LIVER INTERNATIONAL

Saccharomyces boulardii Administration Changes Gut Microbiota and Reduces Hepatic Steatosis, Low-Grade Inflammation, and Fat Mass in Obese and Type 2 Diabetic db/db Mice

(2014) A. Everard et al.   mBio

Symbiotic formulation in experimentally induced liver fibrosis in rats: intestinal microbiota as a key point to treat liver damage?

(2013) Giuseppe D'Argenio et al.   LIVER INTERNATIONAL

Promotion of Hepatocellular Carcinoma by the Intestinal Microbiota and TLR4

(2012) Dianne H. Dapito et al.   CANCER CELL

Butyrate

(2012) Alda J. Leonel et al.   CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE

Lactobacillus johnsonii La1 without antioxidants does not decrease bacterial translocation in rats with carbon tetrachloride-induced cirrhosis

(2012) Germán Soriano et al.   JOURNAL OF HEPATOLOGY

Decline in Topsoil Microbial Quotient, Fungal Abundance and C Utilization Efficiency of Rice Paddies under Heavy Metal Pollution across South China

(2012) Yongzhuo Liu et al.   PLoS One

Current Progress in Antifibroitcs

(2011) S. A.A. El Bialy et al.   CURRENT MEDICINAL CHEMISTRY

Dysbiosis of the faecal microbiota in patients with Crohn's disease and their unaffected relatives

(2011) M. Joossens et al.   GUT

Characterization of fecal microbial communities in patients with liver cirrhosis

(2011) Yanfei Chen et al.   HEPATOLOGY

Gut Microbiota Dysbiosis Is Associated with Inflammation and Bacterial Translocation in Mice with CCl4-Induced Fibrosis

(2011) Isabel Gómez-Hurtado et al.   PLoS One

Efficacy and safety of the probiotic Saccharomyces boulardii for the prevention and therapy of gastrointestinal disorders

(2011) Theodoros Kelesidis et al.   Therapeutic Advances in Gastroenterology

Gut microbiota and probiotics in chronic liver diseases

(2010) Claudia Cesaro et al.   DIGESTIVE AND LIVER DISEASE

Systematic review and meta-analysis ofSaccharomyces boulardiiin adult patients

(2010) Lynne V McFarland   WORLD JOURNAL OF GASTROENTEROLOGY

Enteric defensins are essential regulators of intestinal microbial ecology

(2009) Nita H Salzman et al.   NATURE IMMUNOLOGY

Effect of Unfiltered Coffee on Carbon Tetrachloride-Induced Liver Injury in Rats

(2008) Orhan Kursat Poyrazoglu et al.   INFLAMMATION

Influence of pH conditions on the viability of Saccharomyces boulardii yeast

(2008) Sandrine Graff et al.   JOURNAL OF GENERAL AND APPLIED MICROBIOLOGY